For fuck’s sake…

Mustering solid evidence, two psychiatrists have denounced their field’s standard guidelines for how best to wean patients from depression medications.

In one 2010 study cited in the new paper, Japanese researchers found that 78 percent of people trying to taper off Paxil suffered severe withdrawal symptoms. The research team had them taper much more slowly, over an average of nine months and for as long as four years. With this regimen, only 6 percent of subjects experienced withdrawal.

In another study, Dutch researchers in 2018 found that 70 percent of people who’d had trouble giving up Paxil or Effexor quit their prescriptions safely by following an extended tapering regimen, reducing their dosage by smaller and smaller increments, down to one-fortieth of the original amount. This is the regimen recommended in the new paper.

Read the full NYT article here

And read another article in The Times (paywall) here

Or here at The Huffington Post

So that’s all good then – more and more medical professionals are finally coming round to believing what we, the injured patients, have been saying for years… 

…absolutely… bloody… fucking… YEARS. 

In my case, since Dec 2006, when I started writing this blog.

Seems like it’s still not enough for Prof David Baldwin and Prof Wendy Burn though – they still sayIn the vast majority of patients, any unpleasant symptoms experienced on discontinuing anti-depressants have resolved within two weeks of stopping treatment…”

 

Advertisement

What makes Prof David Baldwin such a bad doctor?

So David Baldwin still insists that the vast majority of patients can stop Seroxat in a couple of weeks and they won’t experience anything more than unpleasant symptoms…

However, the All Party Parliamentary Group for Prescribed Drug Dependence review suggests half of patients have withdrawal symptoms and for half of these the symptoms will be severe.

Patients should be properly warned, it says. Official guidance says symptoms are usually mild and clear up in a week. But the reality is it’s not uncommon for side-effects to last for weeks, months or years in some cases.

The review authors, Dr James Davies, from the University of Roehampton, and Prof John Read, from the University of East London, say about four million people in England may experience symptoms when withdrawing from antidepressants, and about 1.8 million may experience these as severe.

Dr Davies said: “This new review of the research reveals what many patients have known for years – that withdrawal from antidepressants often causes severe, debilitating symptoms which can last for weeks, months or longer.”

“Existing NICE [National Institute for Clinical Excellence] guidelines fail to acknowledge how common withdrawal is and wrongly suggest that it usually resolves within one week. This leads many doctors to misdiagnose withdrawal symptoms, often as relapse, resulting in much unnecessary and harmful long-term prescribing.”

Surely by 2018 we have got to the point where doctors such as Baldwin can no longer ignore the fact that these drugs do a lot of damage to a lot of people. 

1.8 million people.

Everything in the garden isn’t rosy – but Baldwin thinks it is. 

He allows no room for discussion – what happened to me and so many others during withdrawal from anti depressants has no place in Baldwin’s world and that is what makes him such a bad doctor. 

Prof David Baldwin, Prof Wendy Burn & the Royal College of Psychiatrists.

So, I came on this via twitter. It features Prof David Baldwin, Prof Wendy Burn and the Royal College of Psychiatrists.

I think it’s time to get my soapbox out again… 

I take issue with quite a few things in this story, the most outrageous claim being the assertion made by Baldwin & Burn that “… In the vast majority of patients, any unpleasant symptoms experienced on discontinuing anti-depressants have resolved within two weeks of stopping treatment…”

It is very worrying that in 2018 two very high profile mental health professionals can make a statement that is quite so wrong – and dangerous. I really did think we had got beyond this kind of muddle-headed stupidity. And as for Baldwin representing the Royal College of Psychiatrists on an Public Health England expert panel reviewing prescription drug addiction – well, words fail me on that one.

Why would they say something like this? Do they have an agenda? Are there any conflicts of interest that could possibly be in play? 

Or are are they just plain stupid? I have to ask this, as I’m the expert – at least I presume I am – as I guess that Baldwin and Burn have never taken Seroxat and then had to suffer the hell of withdrawal as they tried to stop taking it. I’m not talking about a few “unpleasant symptoms” that “resolved in two weeks” but rather almost two years of absolute horror – physical and emotional – as I slowly reduced the amount of Seroxat I took. 

And I’m not the only one. I suggest that Baldwin and Burn read some of the comments on this blog or take a look at the Facebook group ‘Paroxetine Paxil Seroxat SSRI Withdrawal’ – or maybe just open their eyes and do some research of their own. Maybe even design some proper research. I would think that with Prof Baldwin’s contacts with drug companies perhaps he could get them to pay for the study… or maybe not in this case!

And if we are going to talk about “the vast majority of patients” then it should be in the context that the vast majority of patients do, in fact, often have terrible problems trying to come off Seroxat and other anti-depressants. 

I would ask Baldwin (and Burn) to understand and admit that SSRI withdrawal is a very real problem for many millions of people around the world. Listen to your own colleagues such as Prof Healy or Prof Read – because I know you still don’t really like it when patients talk back at you and have the temerity to question your ‘knowledge’. 

Yes, I am still angry after all these years and no I don’t think I am fully recovered even today, so please forgive me if you see this as just more “vile taunts” or yet another part of “a sustained campaign of abuse”. But I would suggest that the first step for doctors like Baldwin and Burn (and many in the Royal College of Psychiatrists) is to acknowledge the anger of patients who have been so badly let down by the medical establishment and the drug manufacturers, often working in tandem in pursuit of profit – both corporate and personal. 

Then listen to us. 

On a personal level, I think it’s a good thing that Baldwin has resigned from the PHE review panel. His opinions are clearly suspect and his knowledge lacking – and there are further question marks over his close financial ties to drug manufacturers. 

The Daily Mail summed it up like this “A government drugs adviser has been forced out of his position after a sustained campaign of abuse saw him branded ‘worse than Hitler’ and a ‘pharma-whore’, it emerged last night. Professor David Baldwin was subjected to the vile taunts after he wrote an open letter to a newspaper playing down the side-effects of coming off anti-depressants”.

A more measured piece was this from The Times

Me – I think the man’s a fool and wonder what his real motive was for resigning. 

Absolutely nothing to do with ties to drug companies I should hope.

Yes, I know it has been a while…

I’m just in the process of looking back at my time on Seroxat and my withdrawal from it. I can’t say what for at the moment, but watch this space….

Looking back at my blog I can remember how important it seemed at the time to use the internet to get the message out there that there were problems with Seroxat. Of course, over the past 11 years we have come to understand that there are problems with many SSRIs and other drugs. There are also problems with the way big Pharma goes about its business – from rigging drug trials to marketing unsafe drugs to the public.

I’m lucky, I have been able to move on in my life and I leave this blog on the internet to help anyone who is suffering the same way I did in the hope it may be able to help in some small way.

Back in 2005/2006 there was a only handful of us who were using the internet to warn of the problem of Seroxat. Happily now there are far more people and organisations that write about this subject and I hope it’s more widely known by the general pubic and medical professionals alike.

If you haven’t visited these sites, you should:

Leonie Fennell

Dr David Healy

AntiDepAware

GSK: Licence to (K)ill

The Pill that Steals

There’s a trial going on the US at the moment – the crux of the matter in Dolin Vs GSK is whether or not Paxil (Seroxat) caused Stewart Dolin to kill himself whilst under Paxil’s influence – and just what GSK did to hide the truth about the dangers of their drug.

The trial is being covered the mainstream media and by Bob Fiddaman on his blog, and below here are some links to the story so far.

Dolin v GSK – Opening Arguments

Dolin Vs GSK – Day Two – “Jack-In-The-Box”

Dolin vs GSK – Healy ‘Rocks Da House’

Dolin Vs GSK – JP Garnier Video Deposition

Dolin Vs GSK – The Dunbar Tape

Dolin Vs GSK – Day 4 – Slam Dunk

Dolin Vs GSK – 8.9 Suicide Increase For Adult Paxil Users

Dolin Vs GSK – Day 6 – Ass Kicking Semantics

I think that both Bob and I enjoy watching GSK squirm, but what’s important from a wider perspective is the way that a trial brings previously secret information into the public domain. Each trial that takes place opens the curtains a little wider.

I hope that the trial will bring closure for Stewart Dolin’s widow, Wendy. What GSK and their lawyers always forgets is that are real people and real tragedies at the sharp end of the unsafe drugs they choose to bring to market and make huge profits from.

There’s also an action nearing trial in the UK at the moment, and as I wrote previously: The publicity of a High Court hearing will mean the mainstream press  will be free to report on ALL the evidence presented. Now… I’m thinking that this will mean a lot of GSK documents that have until now remained secret will become very public knowledge. You see a case like this, while common in the USA, is unheard of in the UK and the publicity it will generate will be huge. And all those once-secret documents and the information they hold will be available the world over for future claimants to use. I think a whole new raft of claims will be kick-started in the USA alone. I wonder what GSK’s share price will look like after all this? And how institutional investors will view a company that breaks the law and lies & cheats its way to profit?

In the 21st century, ethos & culture – the way a company actually operates and conducts its business – are as important to a PLC as having a blockbuster product to sell. Ethos & culture are intrinsic parts of a modern corporate brand, going way beyond the generic, meaningless mission statement that we see from GSK “…to help people do more, feel better, live longer”.

I’d like to finish on a personal note. Perhaps, after all these years, I’m getting nearer to closure. For me, that simply means people will believe what happened to me was real.

More importantly, I hope that Doctors will understand what happened to me was real – and perhaps then we can start to help others who are going through the horrors of withdrawing from Seroxat/Paxil today.

Seroxat Group action – latest news

Great news about the Seroxat Withdrawal Group Litigation in England… we are on our way to trial! AT LAST!!

I’m sure if you read Bob Fiddaman’s blog you know already – see here – but I thought I’d wait until we had passed the time limit for GSK to appeal Mr Justice Foskett’s judgement to proceed with the Seroxat Withdrawal Group Litigation. That time has passed and there was no appeal… we are on our way to trial! AT LAST!!


If you happen to be one of the group claimants and you HAVE NOT received forms from Fortitude Law in the past 2 weeks, then you should contact Fortitude Law via email at lcorr@fortitudelaw.uk or telephone on 0203 667 3775 without delay.


I think I’ll say it again, just because I can … ‘Judgment has been received from the Honourable Mr. Justice Foskett to proceed with the Seroxat Withdrawal Group Litigation’. 

I think there must be quite a few people on the other side who really thought this had gone away, but I can tell them now to look out – it hasn’t gone away and it’s all too real. I’ve said before that, for me, a trial is the only to resolve this issue

The publicity of a High Court hearing will mean the mainstream press  will be free to report on ALL the evidence presented. Now… I’m thinking that this will mean a lot of GSK documents that have until now remained secret will become very public knowledge. You see a case like this, while common in the USA, is unheard of in the UK and the publicity it will generate will be huge. And all those once-secret documents and the information they hold will be available the world over for future claimants to use. I think a whole new raft of claims will be kick-started in the USA alone. I wonder what GSK’s share price will look like after all this? And how institutional investors will view a company that breaks the law and lies & cheats its way to profit?

In the 21st century, ethos & culture – the way a company actually conducts its business – are as important to a PLC as having a blockbuster product to sell. Ethos & culture are intrinsic parts of a modern corporate brand, going way beyond the generic, meaningless mission statement that we see from GSK.

I’d like to finish on a personal note. Perhaps, after all these years, I’m getting nearer to closure. For me, that simply means people will believe what happened to me was real.

More importantly, I hope that Doctors will understand what happened to me was real – and perhaps then we can start to help others who are going through the horrors of withdrawing from Seroxat/Paxil today.

 

 

A history of SSRIs

This is a re-post from something I wrote in March 2007 – on reflection, perhaps it should be more accurately entitled A History of SSRIs and the Damage they do to Patients.

I think there may well be a lot of discussion in the coming months about Seroxat dependency and the terrible withdrawal symptoms that many people have to endure as they try to stop taking Seroxat and so I think that the download – A History of SSRIs  is more relevant today than ever.

Looking at my original post, I was remiss as I didn’t credit the author of the download – so belated apologies to Prof David Healy (I think it’s his piece).

Now read on:

Over the years I have collected a few interesting documents and I think it’s just plain selfish to keep them to myself so I’m starting to share them with you.

The one for download here – A History of SSRIs is exactly what it says it is… a history of SSRIs.

You can read about the first SSRI – Zelmid – which was patented in 1972 and made it to market in 1982 before any of the others. I suppose not many of you remember Zelmid though as it was discovered in rare cases to cause a serious neurological disorder called Guillain-Barré Syndrome. This potentially fatal disorder led to the immediate removal of the drug from the market.

But Astra had already begun the development of a derivative of Zelmid, called alaproclate, when Zelmid ran into trouble. Alaproclate was being investigated for both depression and Alzheimer’s disease. But it caused liver problems in one strain of laboratory mice and this was enough to lead Astra to drop it. Shortly after this, Astra introduced an innovative antipsychotic, remoxipride, which looked like it would have significantly fewer side effects than older agents. Several months after its launch, however, remoxipride was reported to cause aplastic anemia in a small number of people and it too was withdrawn.

Notice a pattern here?

And did you know this about Prozac? As Eli Lilly were trying to launch Prozac in Germany they came up against a slight problem with the view of the German regulators on fluoxetine (Prozac) as of May 1984: “Considering the benefit and the risk, we think this preparation totally unsuitable for the treatment of depression”.

A History of SSRIs is an enlightening document – with a large section on Seroxat…

 

 

Seroxat/Paxil Study 329 – the truth at last.

I’m feeling re-energised today for a number of reasons, one of them being the fact that I’ve discovered the final chapter in the story of Study 329 has arrived.

I suggest you visit Restoring Study 329 for the latest news.

Also have a look here at Bob Fiddaman’s excellent take on today’s news.

If you don’t already know, Study 329 is arguably the most controversial drug study ever, published in July 2001.

In a nutshell Study 329:

– concluded that Seroxat was a safe and effective medication for treating major depression in adolescents;
– is still widely cited in the medical literature, providing physicians with assurance about the usefulness of paroxetine;
– was criticised by a few alert and concerned journalists, academics and bloggers. (However, their voices were buried by a tsunami of positive marketing and promotion by vested interests);
– resulted in a successful New York state fraud lawsuit against GSK;
– resulted in 2012 in the biggest fine in corporate history – $3 Billion,
and
– remains unretracted.

I have written about the scandal of Study 329 for many years and this link collects my posts about the Study 329.

From one blunt Yorkshireman to another – I hope you’re paying attention Andrew Witty, this hasn’t gone away… oh, and I don’t just mean Study 329.

What I believe

I believe Seroxat is defective and dangerous.

I believe that Glaxo has hidden clinical trial data that shows exactly how dangerous a drug it is.

I believe that Seroxat is addictive.

I believe that Seroxat can cause anger, aggression and violence.

I believe that something must be done to help people who suffer terrible problems with withdrawal, as they desperately try to stop taking Seroxat.

I believe that doctors have taken large sums of money from Glaxo to lie about the efficacy and safety of the drug.

I believe that GlaxoSmithKline puts profits before patients – their wealth before our health.

I took Seroxat for 9 years and it took me 22 months to withdraw from the drug little by little.

Believe me – I know what I’m talking about.

The Antidepressant Era: the movie

No apologies here, this article (and videos) have been lifted straight from David Healy’s excellent website.

It’s important that as many people as possible have the chance to read the piece and take time to watch the film.

As far as the pharmaceutical industry is concerned, I can tell you from first hand experience that the industry still believes in its own hype… do more, feel better and live longer is Glaxo’s strapline and no one in that company thinks there’s even a hint of irony in that.

Now for Dr Healy’s piece:

The Antidepressant Era: the movie

The Antidepressant Era was written in 1995, and first published in 1997. A paperback came out in 1999. It was close to universally welcomed – see reviews 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 . It was favorably received by reviewers from the pharmaceutical industry, perhaps because it made clear that this branch of medical history had not been shaped by great men or great institutions but that other players, company people, had been at least as important.

Nobody objected to it, perhaps because at this point I had not agreed to be an expert witness in a pharmaceutical induced injury case. There were likely no PR companies who had a brief to manage Healy. I knew before The Creation of Psychopharmacology came out in 2002 that the response to it would be very different.

Disease Mongering & the Myth of Lowered Serotonin

Many of the ideas in The Antidepressant Era had appeared earlier. The idea that a lowering of serotonin (chapter 5) was a marketing myth and had nothing to do with science, first appeared in my doctoral thesis in 1985, and later in Psychopharmacological Revolutions in 1987. The idea that companies market diseases as a way of marketing medicines (chapter 6) first appeared in 1990 in Notes toward a History and The Marketing of 5HT.

The Antidepressant Era in turn contained many of the elements of Pharmageddon – the key role of the 1962 amendments to the Food and Drugs Act which, through product patents, prescription-only status for new drugs and the role of clinical trials, have created modern healthcare.

Is Valium a better drug than Prozac?

In 2000 I was approached by Duncan Dallas, an independent television producer from Leeds who wanted to do something critical on the antidepressants. Prozac was still at this point widely seen as a miracle of modern medicine, rather than an inferior drug to older antidepressants. Bioethicists and social scientists were still lining up to herald the creation of the New Man through modern genetics and modern psychotropic drugs.

Saying that what we were witnessing was a triumph of modern marketing rather than modern science caused a frisson in most circles. There were no natural allies – not in psychopharmacology or biological psychiatry but not in social science circles either.

But this is what Duncan wanted. The Antidepressant Era, the movie, opens with some of the hype around SSRIs, has astonishing footage of Roland Kuhn and Alan Broadhurst, two of the key people behind the discovery of imipramine, and outlines the overthrow of the benzodiazepines and their replacement by antidepressants.

It shows how rating scales and screening are used in psychiatry to create problems for which a drug becomes the answer.  It was the first program to wheel on stage the marketing men who created the social anxiety campaigns that sold Paxil, and it outlined the role of DSM III in the creation of depression.

Duncan’s version has a wonderful artistry. The book opens with a quote from George Oppen’s The Skyscraper. The “movie” closes with the same quote.

The Building of the Skyscraper

The steelworker on the girder
Learned not to look down, and does his work
And there are words we have learned
Not to look at,
Not to look for substance
Below them. But we are on the verge
Of Vertigo.

There are words that mean nothing
But there is something to mean.
Not a declaration which is truth
But a thing
Which is ..

Oh, the tree, growing from the sidewalk –
It has a little life, sprouting
Little green buds
Into the culture of the streets.
We look back
Three hundred years and see bare land.
And suffer vertigo.

Downfall – Adolf  Who? 

Its central moment is an astonishing sequence featuring the then President of Hoffman-la-Roche, Adolf Jann, embarking on a rant that looks now like an uncanny forerunner of the famous Adolf Hitler rant in the movie Downfall. The rant that launched a thousand You-Tubes. Adolf Jahn thumps his fist on the table, voice rising, as he angrily tells an interviewer in effect “You – none of you – can do without us – just try”. See section at 20 minutes 50 seconds to 22 minutes.

There is nothing specific to Jann or Roche here. This was and is the common credo of the pharmaceutical industry. This is what the CEOs of GSK, Pfizer, Merck and Lilly are saying to governments today. Healthcare is not sustainable unless we develop drugs that get people well so they aren’t a burden on the State, and if healthcare is not sustainable democracy may not be either. Facilitate us or society as you know it goes down the drain.

It would be a mistake to see this as a horrible modern manifestation of rapacious capitalism. Socialists from George Bernard Shaw in the early twentieth century onwards have turned to biology as an answer to social problems. If we cannot get mankind to agree to change for the better, perhaps we can improve on mankind. This belief powered the efforts of governments to eliminate the unfit from the late nineteenth century through to the eugenics movement and underpins some of our hopes for the New Genetics.

Eugenics looks terrible in retrospect while modern genetics looks like our only hope – but the same impulse underpins both.  There is no better example of what good history is about than this. Anyone writing the history of eugenics should really portray its prime movers in the same light as we now portray the heroes of the the Human Genome Project.

We should always remember that the nominees for the 1937 Nobel Peace Prize included both Gandhi and Hitler. There was a time when one looked at least as likely as the other to contribute to modern civilization.

Revolution’s Little Helper

The same dynamic made Valium look like a very dark drug in 2000 – so that even its name was withdrawn. Prozac in contrast looked like the gateway to the hoped for shiny uplands of the future, when by the mid-1990s Prozac should have been seen as a far darker drug than Valium.

Valium entered a world in which psychiatry in many ways led medicine as it had done for almost a hundred years. Psychiatry was the first branch of medicine to have specialist hospitals and specialist journals. And Valium really did work remarkably well. Far from being simply a superficial treatment it likely led to the disappearance of catatonia and saved a lot of lives.

Valium probably did a lot to stimulate the Revolution of 1968. The conventional wisdom now is that Valium was Mother’s Little Helper and in this role that it played a part in the imprisonment of women in suburbia. In fact, Valium and other benzodiazepines undo conditioned avoidance. They were advertised initially as being among other things useful for salesmen – to overcome their inhibitions. They almost certainly disinhibited many women to speak out against patriarchy. They helped students breach the double-binds that Ronnie Laing and others in the 1960s were preaching were holding back society.

Prozac and the SSRIs in contrast far more often produce an apathy that is destructive to engagement in society as Who Cares in Sweden shows.  Prozac, Paxil, Zoloft, Efexor, Pristiq, and Cymbalta are far more likely to lead to suicide and murderous violence including school shootings than Valium ever did. And the SSRIs lead to just as many cases of dependence as the benzos ever did.

Tamiflu – PharMessiah?

Are we incapable of learning? Will we always be seduced by the latest PharMessiah?

The Antidepressant Era, the movie, contains an extraordinary comment on just this that no one could have foreseen when it was finished in 2001. It almost looks like the Scriptwriter in the Sky must have inserted the clip of Adolf Jahn telling us that if we don’t facilitate him and Roche society will collapse. We can only afford to keep our economy and society going if he and his company are let develop new drugs.

Well Roche got to develop Tamiflu. Where Valium was the headline drug in the 1980s for the problems a rampant pharmaceutical industry might pose, Tamiflu is now. Governments throughout the Western world stockpiled billions of dollars worth of Tamiflu on the promise that it would prevent the transmission of influenza and other viruses, and would either keep people in work or get them back to work faster, thus saving our economies huge amounts of money.

Except the drug now appears to be close to worthless and to have always been so. It seems that the impression that Tamiflu might help could only have been created because companies can hide the existence of many and in some cases most of their clinical trials and hide the data from all of them, ghostwriting the ones that are published in a manner that keeps all data out of the public domain.

Facilitate us too much and we will lead to your Downfall.

Stephen Whitehead, ABPI – missing the point completely

I read this article in the New Statesman today and made me really quite annoyed…

It featured a letter written to the New Statesman by the CEO of the Association of the British Pharmaceutical Industry (ABPI), Stephen Whitehead, as a response to issues Ben Goldacre’s new book, Bad Pharma.

It’s amazing just how stupid a response it is – in fact I have to ask if Stephen has actually bothered to read the book at all or if the’s just gone into classic big Pharma knee jerk mode (after all, Stephen did spend 10 years of his career working at Glaxo and Eli Lily).

But no matter, as the New Statesman has printed Ben’s reply to the response.

However the comment I really found strange from Stephen Whitehead was this “…references to companies (GSK, Lilly, Pfizer) being fined are all examples from the US and simply not relevant to the UK market…”

GSK’s fine was, to remind you, the largest healthcare fraud settlement in history at $3bn.

How it isn’t relevant to the UK is beyond me – because what we’re talking about here is not just illegal marketing of drugs – not just bribing doctors to prescribe GSK products – what we’re talking about here are dead people.

Patients died because they were taking drugs that weren’t safe, drugs that weren’t even approved for their treatment.

In the case of Avandia, the drug is so dangerous that it can no longer be prescribed in Europe – it had to be withdrawn from the market because of high levels of heart attack, heart failure and stroke in patients. It had to be withdrawn from the market because it killed too many people.

How’s that “simply not relevant” to patients in the UK, Stephen?

%d bloggers like this: